Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_4
1
25%
Ph phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 1Safety & dosage
1(50.0%)
Phase 4Post-market surveillance
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Active, not recruiting1
Completed1
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (50.0%)
Phase 41 (50.0%)

Trials by Status

active_not_recruiting125%
completed125%
not_yet_recruiting125%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
not_yet_recruiting

A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors

NCT07046780
active_not_recruiting

Effect of HCG on Endometrial Preparation in Frozen Embryo Transfer

NCT06577181
unknownphase_4

Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma

NCT01765231
completedphase_1

Umbilical Cord Blood Transplant for Hematological Malignancies

NCT00891592

Clinical Trials (4)

Showing 4 of 4 trials
NCT07046780

A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors

Not Yet Recruiting
NCT06577181

Effect of HCG on Endometrial Preparation in Frozen Embryo Transfer

Active Not Recruiting
NCT01765231Phase 4

Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma

Unknown
NCT00891592Phase 1

Umbilical Cord Blood Transplant for Hematological Malignancies

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4